These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9234529)

  • 21. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
    Sedegah M; Jones TR; Kaur M; Hedstrom R; Hobart P; Tine JA; Hoffman SL
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7648-53. PubMed ID: 9636204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.
    Narum DL; Kumar S; Rogers WO; Fuhrmann SR; Liang H; Oakley M; Taye A; Sim BK; Hoffman SL
    Infect Immun; 2001 Dec; 69(12):7250-3. PubMed ID: 11705894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates.
    Limbach K; Aguiar J; Gowda K; Patterson N; Abot E; Sedegah M; Sacci J; Richie T
    Malar J; 2011 Mar; 10():65. PubMed ID: 21410955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.
    Zheng L; Pang W; Qi Z; Luo E; Cui L; Cao Y
    Parasit Vectors; 2016 Aug; 9(1):433. PubMed ID: 27502144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.
    Doolan DL; Sedegah M; Hedstrom RC; Hobart P; Charoenvit Y; Hoffman SL
    J Exp Med; 1996 Apr; 183(4):1739-46. PubMed ID: 8666931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
    Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
    Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein.
    Wang HH; Rogers WO; Kang YH; Sedegah M; Hoffman SL
    Mol Biochem Parasitol; 1995 Feb; 69(2):139-48. PubMed ID: 7770079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological responses of neonates and infants to DNA vaccines.
    Sedegah M; Hoffman SL
    Methods Mol Med; 2006; 127():239-51. PubMed ID: 16988458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
    Wang R; Charoenvit Y; Daly TM; Long CA; Corradin G; Hoffman SL
    Immunol Lett; 1996 Nov; 53(2-3):83-93. PubMed ID: 9024983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new malaria antigen produces partial protection against Plasmodium yoelii challenge.
    Zhang Y; Qi Y; Li J; Liu S; Hong L; Lin T; Long C; Su XZ
    Parasitol Res; 2012 Apr; 110(4):1337-45. PubMed ID: 21915626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.
    Iyori M; Nakaya H; Inagaki K; Pichyangkul S; Yamamoto DS; Kawasaki M; Kwak K; Mizukoshi M; Goto Y; Matsuoka H; Matsumoto M; Yoshida S
    PLoS One; 2013; 8(8):e70819. PubMed ID: 23951015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First DNA malaria vaccine on trial in Africa.
    Ferry G
    Curr Biol; 2000 Nov; 10(22):R810-1. PubMed ID: 11102816
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.
    Srinivasan P; Ekanem E; Diouf A; Tonkin ML; Miura K; Boulanger MJ; Long CA; Narum DL; Miller LH
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10311-6. PubMed ID: 24958881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein.
    Persson C; Oliveira GA; Sultan AA; Bhanot P; Nussenzweig V; Nardin E
    J Immunol; 2002 Dec; 169(12):6681-5. PubMed ID: 12471098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s).
    Lucas B; Engels A; Camus D; Haque A
    Infect Immun; 1993 Nov; 61(11):4863-9. PubMed ID: 8104901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
    Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
    J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.